查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质表达市场：市场规模、份额、趋势分析、机会、预测——按系统类型、应用、最终用户、地区划分 (2019-2029)
市场调查报告书
商品编码
1227606

全球蛋白质表达市场：市场规模、份额、趋势分析、机会、预测——按系统类型、应用、最终用户、地区划分 (2019-2029)

Protein Expression Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By System Type ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球蛋白表达市场规模将在 2022 年达到 31.2 亿美元，到 2029 年达到 71.6 亿美元，在 2023-2029 年的预测期内以 12.63% 的复合年增长率增长。

由于生物製药公司增加了对蛋白质表达研发的投资以及越来越多地采用基于重组的蛋白质表达，因此全球市场正在蓬勃发展。

本报告考察了全球蛋白表达市场，并提供了市场洞察、市场概况、区域市场分析、竞争格局、公司概况等资讯。

内容

第 1 章研究框架

第 2 章执行摘要

第 3 章全球蛋白质表达市场洞察

  • 工业价值链分析
  • DROC 分析
    • 促进因素
      • 对蛋白质生物製剂的需求增加
      • 增加製药和生物製药行业的研发
      • 越来越多地采用基于重组的蛋白质表达
      • 蛋白质研究的资金可用性
    • 抑制因素
      • 蛋白表达试剂和设备成本高
      • 整合程度提高，新进入者门槛高
    • 机会
      • 微流体的出现
      • 具有巨大增长潜力的新兴经济体
    • 任务
      • 不良的翻译后修饰和纯化
  • 技术进步/最新发展
  • 监管框架
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争激烈程度

第 4 章全球蛋白表达市场概述

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
      • 哺乳动物细胞表达系统
      • 原核表达系统
      • 昆虫细胞表达系统
      • 酵母表达系统
      • 无细胞表达系统
      • 基于藻类的表达系统
    • 按使用
      • 治疗
      • 研究
      • 工业
    • 最终用户
      • 製药和生物技术公司
      • 承包研究机构/承包开发和製造组织 (CROS/CDMOS)
      • 学术研究所
      • 其他
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲

第 5 章北美蛋白表达市场

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
    • 按使用
    • 最终用户
    • 按国家
      • 美国
      • 加拿大

第 6 章欧洲蛋白表达市场

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
    • 按使用
    • 最终用户
    • 按国家
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 荷兰
      • 其他欧洲

第 7 章亚太蛋白表达市场

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
    • 按使用
    • 最终用户
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印度尼西亚
      • 马来西亚
      • 新加坡
      • 菲律宾
      • 越南
      • 亚太其他地区

第 8 章拉丁美洲的蛋白质表达市场

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
    • 按使用
    • 最终用户
    • 按国家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 哥伦比亚
      • 其他拉丁美洲

第 9 章中东和非洲的蛋白质表达市场

  • 2019-2029 年市场规模和预测
    • 按金额（十亿美元）
  • 市场份额/预测
    • 按系统类型
    • 按使用
    • 最终用户
    • 按国家
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • 其他中东和非洲地区

第10章竞争格局

  • 主要公司和产品列表
  • 2022 年全球蛋白表达公司市场份额分析
  • 竞争基准：按运营参数
  • 重大战略发展（合併、收购、合作等）

第 11 章 COVID-19 对全球蛋白表达市场的影响

第 12 章公司概况（公司概况、财务矩阵、竞争格局、主要人员、主要竞争对手、联繫地址、战略前景、SWOT分析）

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Agilent Technologies, Inc.
  • Takara Bio, Inc.
  • Bio-Rad Laboratories, Inc
  • Qiagen N.V
  • Charles River Laboratories, Inc.
  • Danaher Corporation
  • Sartorius AG
  • Corning Incorporated
  • FUJIFILM Irvine Scientific, Inc.
  • Lonza Group AG
  • Bioneer Corporation
  • Promega Corporation
  • Oxford Expression Technologies Ltd
  • 其他有影响力的公司

第 13 章关键战略建议

第 14 章研究方法论

简介目录
Product Code: BWC23135

Global Protein Expression Market Size More Than Doubles to Reach USD 7.2 Billion by 2029.

The global protein expression market is gaining traction because of the increasing investments in R&D protein expression by biopharmaceutical companies and growing adoption of recombinant-based protein expression.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global protein expression market size at USD 3.12 billion in 2022. During the forecast period between 2023 and 2029, the global protein expression market size is projected to grow at an impressive CAGR of 12.63% reaching a value of USD 7.16 billion by 2029. The growing use of protein expression in the biopharmaceutical and life sciences sector for the development of novel medications and treatments is one of the major growth reasons for the global protein expression market. Protein expression is the subject of intensive research and development efforts as a result of the rising incidence of cancer and other chronic diseases throughout the world, which is fueling the market's expansion.

Global Protein Expression Market - Overview:

The process through which proteins are created, altered, and controlled in living organisms is referred to as protein expression. The analysis of protein expression in cancer cells may provide details about a particular type of cancer, the optimal course of treatment, and the effectiveness of a particular course of treatment. For further studies, such as identifying the three-dimensional structure of proteins, as chemical instruments or probes, or as novel classes of pharmaceuticals, among others, expressed protein products that are functional and exhibit traits comparable to their native counterparts are helpful.

Global Protein Expression Market - By End User:

Based on end users, the global protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract development and manufacturing organizations (CROs and CDMOs), academic research institutes, and others. The pharmaceutical and biotechnology company segment accounts for the highest market share. Protein expression is widely used in pharmaceutical and biotechnology companies to carry out research and develop new drugs. CROs are also gaining traction owing to increasing outsourcing of research activities at lower costs which helps companies increase their profit margins.

Impact of COVID-19 on Global Protein Expression Market

The unprecedented COVID-19 pandemic outbreak brought various growth opportunities for the global protein expression market. According to earlier research, the novel coronavirus infects people via infecting epithelial cells by connecting with the human ACE2 receptor protein on their surface. As a result, extensive research activities surrounding the study of the protein expression status of angiotensin-converting enzyme 2 (ACE2) to understand the hypothesized correlation of the level of ACE2 expression in lungs with an increased risk of severe infection and complications in COrona VIrus Disease 2019 (COVID-19). Several other types of research like these with the application of protein expression also played a crucial role in tackling the COVID-19 pandemic.

Competitive Landscape:

Major players operating in the global Protein Expression market include: Thermo Fisher Scientific, Inc., Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Inc., Takara Bio, Inc., Bio-Rad Laboratories, Inc, Qiagen N.V, Charles River Laboratories, Inc., Danaher Corporation, Sartorius AG, Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Lonza Group AG, Bioneer Corporation, Promega Corporation, and Oxford Expression Technologies Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Protein Expression Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Protein Expression Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Protein Expression Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Protein Expression Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing demand for protein biologics
      • 3.2.1.2. Increasing R&D in pharmaceutical and biopharmaceutical industries
      • 3.2.1.3. Growing adoption of recombinant-based protein expression
      • 3.2.1.4. Availability of funding for protein-based research
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of protein expression reagents and instruments
      • 3.2.2.2. Increasing consolidation and high barriers for new entrants
    • 3.2.3. Opportunities
      • 3.2.3.1. Emergence of microfluidics
      • 3.2.3.2. Emerging economies offering significant growth potential
    • 3.2.4. Challenges
      • 3.2.4.1. Undesired post-translational modifications and purification
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Protein Expression Market Overview

  • 4.1. Market Size & Forecast by Value, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By System Type
      • 4.2.1.1. Mammalian Cell Expression Systems
      • 4.2.1.2. Prokaryotic expression systems
      • 4.2.1.3. Insect cell expression systems
      • 4.2.1.4. Yeast expression systems
      • 4.2.1.5. Cell-free expression systems
      • 4.2.1.6. Algal-based expression systems
    • 4.2.2. By Application
      • 4.2.2.1. Therapeutic
      • 4.2.2.2. Research
      • 4.2.2.3. Industrial
    • 4.2.3. By End User
      • 4.2.3.1. Pharmaceutical and Biotechnology companies
      • 4.2.3.2. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)
      • 4.2.3.3. Academic Research Institutes
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Protein Expression Market

  • 5.1. Market Size & Forecast by Value, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By System Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. US
      • 5.2.4.1.1. By System Type
      • 5.2.4.1.2. By Application
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By System Type
      • 5.2.4.2.2. By Application
      • 5.2.4.2.3. By End User

6. Europe Protein Expression Market

  • 6.1. Market Size & Forecast by Value, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By System Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By System Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By End User
      • 6.2.4.2. UK
      • 6.2.4.2.1. By System Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By System Type
      • 6.2.4.3.2. By Application
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By System Type
      • 6.2.4.4.2. By Application
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By System Type
      • 6.2.4.5.2. By Application
      • 6.2.4.5.3. By End User
      • 6.2.4.6. The Netherlands
      • 6.2.4.6.1. By System Type
      • 6.2.4.6.2. By Application
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Rest of Europe
      • 6.2.4.7.1. By System Type
      • 6.2.4.7.2. By Application
      • 6.2.4.7.3. By End User

7. Asia Pacific Protein Expression Market

  • 7.1. Market Size & Forecast by Value, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By System Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By System Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By System Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By System Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By System Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By System Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By System Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By System Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By System Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Philippines
      • 7.2.4.9.1. By System Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Vietnam
      • 7.2.4.10.1. By System Type
      • 7.2.4.10.2. By Application
      • 7.2.4.10.3. By End User
      • 7.2.4.11. Rest of APAC
      • 7.2.4.11.1. By System Type
      • 7.2.4.11.2. By Application
      • 7.2.4.11.3. By End User

8. Latin America Protein Expression Market

  • 8.1. Market Size & Forecast by Value, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By System Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By System Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By System Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By System Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By System Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Colombia
      • 8.2.4.5.1. By System Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By End User
      • 8.2.4.6. Rest of LATAM
      • 8.2.4.6.1. By System Type
      • 8.2.4.6.2. By Application
      • 8.2.4.6.3. By End User

9. Middle East & Africa Protein Expression Market

  • 9.1. Market Size & Forecast by Value, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By System Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By System Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By System Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By System Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By System Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By System Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By System Type
      • 9.2.4.6.2. By Application
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By System Type
      • 9.2.4.7.2. By Application
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By System Type
      • 9.2.4.8.2. By Application
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Protein Expression Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Protein Expression Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Merck KGaA
  • 12.3. GenScript Biotech Corporation
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Takara Bio, Inc.
  • 12.6. Bio-Rad Laboratories, Inc
  • 12.7. Qiagen N.V
  • 12.8. Charles River Laboratories, Inc.
  • 12.9. Danaher Corporation
  • 12.10. Sartorius AG
  • 12.11. Corning Incorporated
  • 12.12. FUJIFILM Irvine Scientific, Inc.
  • 12.13. Lonza Group AG
  • 12.14. Bioneer Corporation
  • 12.15. Promega Corporation
  • 12.16. Oxford Expression Technologies Ltd
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumption & Limitation